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More than 3,000 automatic implantable cardiorsr;er- 
defibrillator (AICD) pulse generators have now been I,,,- 
slanted in 2.500 oatients bincc the inina! series of 57 MD 
&orators, ihi& concluded in 1982 tpersooat commuoica- 
tion). lncloding the report published in this issue oi the 
Journal (I), published studies ofimplantation techniques and 
AICD follow-uo in eeer review iournals aooroximate 10% of 
the total imp&a& experi&e. Multiple reporting of 
cases by the same or even different authors makes exact 
determination of the number of cases reported im~~ible. 
Review of Figure I demonstrates II imprcuive growth rate 
of new implants whereas follow-up reports have appcsred at 
a considerably slower pace. This experience is progressively 
becoming mo~c broadly distributed among more lhan 200 
implantation centers. resulting in a growing number of 
implanting physicians on the initial ascent of the AlCD 
“learning curve” xeking to supplement their knowledge 
from published repons. As more manufacturers of similar 
devices entei the field, their productr will he compared with 
the AICD. As expressed in a went editorial (2). because of 
the wide variability in reporting of implantation methodol- 
ogy, complications and follow-up data. those endeavoring to 
derive specific information or perform comparisons from this 
literature will be confronted with no unenviable task. 
Rok of amicderene in detibrilatiw onarry requirements. 
The article in this issue (IL and the antecedent published 
AICD extwicnce WZ), appropriately explores the impres- 
sively low anhythmic mortality associated with the AICD. 
Collectively. these papers have also elaborated on compti- 
cations of the AlCD and classified the perceived propriety of 
AICD discharges. Kelly et al. !I) have noted. es did we (13). 
en bswcmtion or amioderone edministration with higher 
energy requiremoms for ventricular defibrillstioa They also 
obwrvcd en mcreased incidence of patoperetive ventricular 
tachycrrdia in patients with epimyocardial rate-counting 
leadi dnd of atrial arrhythmias in those wth patch-patch 
defihnllaiion electrode systems. ‘fbese statistical inferences 
JO not necesranly imply biolo$c significance or a caosel 
~?li~tloo bctwccn these phenomena. The observation. how 
ever. Ihat defibnllatian energy requirements in patients aho 
had never taken or had previously discontinued amiodxone 
were lower than in patients taking thn ager et AICD 
implantawn lends credence to the tenet that this effect may 
he drug related rather than due to mtluences of “thcr 
variables potentially idiosyncratic to the amiodarone-treated 
%KWP. The dinparity between these observations in humane 
and those obtained in dogs (1.13-151 underscores the need 
for additional study as well as for uniform methods of 
dctermaning energy requirements within species. 
The majority of reports. including the prewnt one (I). 
provide a dearth of information regarding preoperative vei- 
uation mcrhcds. imptao?ation methodology. defibriliation 
ei?tcacy testing and correlation of wiables other thee the 
AICD with clinical outcome and survival. These details are 
important in attempting to compare one series with another. 
assess overall frequency of technique-related complications 
and define the inRuence of other clinical variables on AlCD 
Yxformance. arrhylhmic and loreI mortality. 
Freimpknt W&rs predictive of AKD diseherg+r. Al- 
though stress testing is rctmapectively advocated (I). only B 
sin@ repon (5) states that prcopcrative exercise testing was 
performed in all cases. Only two publications (5.12) mention 
that preoperative ambulatory electrocardiographic WC) 
recording was routinely perfomted and no study addresses 
QRS confipumtioe during normal rhythm on the surface 
ECG. These and other aspects of testingbefore implantation 
may correlate with or prognosticate postopemtive AlCD 
discharger and may influence lhe incidence of discharges. 
AICDdischargesarc seldom considered in thecontext of the 
frequency of prcinplantation arrhythmias or the rcsulis of 
oreimolentation testinn other then vromemmed ventricular 
&&ion. The euth& of the rep&x ii this issue (1) found 
that only induction of sustained ventricular techycardia with 
one or two extrastimuli is predictive of shocks during 
symptomatic ventricular arrhythmias (161. Similar evalub 
tion is necessary to esscss the predictability of inappropriate 
AICD discharges. 
Surgical implpntauon end Dkctrede cwsideraliew. AI- 
though vinuelly all of the published studies comment on the 
method of sun$cal entry into the chest and defibrillating 
electrode sizes. sane. perhaps equally impmtent, details arc 
seldom addressed. Tbesc include intrapericadiat or extra- 
pericardial patch electrode placement, electrode orientation. 
electrode fixation and electrode polarity. The tacit assump 
lion appears to have been made that structurally similar 
dcfibrillating lead systems are funclionally equivalent. 
Spring electrode positioning has ranged from superior vena 
cavaW,superior vena cave-righratrialjunction(l7,18), high 
npht atrium (5). 3 to 4 cm distal to the superior vena 
cava-ripht atrial iunction (6) and mid-rieht atrium (131. Patch 
locat& have &ied from left vcntri~ular a&(S.lb191, 
lateral (131, or “apical posterolateral” (6) left ventricular 
wall when paired with aspring electrode. Eleclrode orienta- 
tioo in two patch systems has been described as anterior- 
posterior (6,12,13), right atrium-apex or apicolateral (4.8). 
inierior-anterior (201 and inferior-Dastcrolateral 1% The 
foregoing does not suggest hat th&e is a universally ac- 
cepted method olelectrode application. Although all ofthcse 
methods eem to accomplish their desired goals. compmison 
of defibrillation eficacy among these various implantation 
techniques is essentially precluded because of other metho- 
dologic diEerences. 
Defibrillation e&aey and defibrillation threshold testing. 
Testmg of defibrillation efficacy is infrequently detailed in 
depth. but a majority of studies allude to determinadon of a 
defibrillation “threshold.” Although a true threshold for 
dchbrillation appears not to exist t21.22). a method that will 
provide relative comparison of defibrillating lead systems 
and establish a safety margin for defibrillation and a uniform 
protocol for makinr such measurements with few fibrillation 
inductions in hum& is clearly needed. Some investigators 
believe that determining a single defibrillation threshold has 
utility (23.241 whereas othersadvise interpreting such mea- 
wrements ?t:ith caution (22). Because defibrillation energy 
requirements may be partially time dependent (25.261, the 
duralion of fibrillation at which threshold data are obtained 
Figure 1. Experience with the wto- 
matic im~lnnmbte cardiovencr-dcfi. 
brillator t*tCD) since 1982. 
should he stated and. ideally, should be standardized. Shock 
sequencing within the testing protocol may also influence the 
observed defibrillation threshold (22). Guidelines regarding 
energy requirements for AtCD implantation have been pro- 
mulgated (27) and experience appears to substantiate these 
recommendations. but the optimal safety margin for various 
defibrillation lead systems and waveforms has not been 
unequivocally established. This will assume enhanced im- 
portance in the near future when AiCDs with programmable 
energy delivery capacity become available. Uniform proto- 
cols for arrhythmia duration, shock sequencing and efficacy 
determination are necessary if useful information is to be 
gained from the burgeoning implant experience. 
Future studier. The erowth rate of the AICD im&mts 
leaves little doubt that this technology is gaining accepfance. 
Efficacy of the AIDB, AID-BR and Ventak seems con- 
firmed by all reports. Despite the gaps in our present 
knowledge regarding testing of the AICD. the device has an 
enviable track record that has been accomolished with 
relatively few modifications over the past 6 years. In reports 
of additional studies of this device the methodology should 
be sufficiently detailed to permit comparison with past as 
well as future changes in this technology. The emphasis of 
future repons should perhaps hift from describing~benom- 
ena to testing hypotheses. 
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